Home Blog Page 47

YF Life Claims “Branding Initiative of the Year – HK” at Insurance Asia Awards 2026

Pioneering “Invesurance” Philosophy for 50th Anniversary Campaign Secures Prestigious Industry Honor


HONG KONG SAR – Media OutReach Newswire – 6 August 2026 – YF Life Insurance International Ltd. (YF Life) has been awarded the prestigious “Branding Initiative of the Year – Hong Kong” accolade at the Insurance Asia Awards 2026. This prominent recognition celebrates the resounding success of YF Life’s 50th-anniversary brand campaign, which highlighted its pioneering “Invesurance” (Insurance + Investment) philosophy. This award underscores YF Life’s commitment to comprehensive brand transformation, the establishment of a revolutionary insurance-investment framework, and its industry-leading position in marketing innovation.

Mr. Stephen Zhang, Executive Director and Chief Executive Officer of YF Life, stated: “We are honored to receive this prestigious recognition. This award is not only the ultimate tribute to YF Life’s 50th anniversary milestone, but also an authoritative endorsement of our ‘Invesurance’ philosophy, which strategically and deeply integrates the rigors of investment with the security of insurance. Navigating a dynamic market landscape and the sophisticated expectations of next-generations, YF Life remains resolute in our commitment to driving sustainable asset growth and financial resilience. The resounding success of this campaign marks a pivotal milestone, propelling us forward into an increasingly digitalized, youth-centric, and globally integrated future.”

Defining “Invesurance”: Setting the Standard for Systematic Insurance Wealth Management

As the core of the 50th-anniversary campaign is the “Invesurance” philosophy, a pioneering approach within the Hong Kong and Macau insurance sectors that proactively bridges the divide between investment and insurance. This framework is anchored by four strategic pillars:

  • The “1+N” Structure: Collaborating with Barings to manage high-quality core bond portfolios “1”, while closely partnering with world-class asset management institutions “N” to strategically deploy private equity and alternative investments, providing flexible access to diversified investment vehicles.
  • Risk Diversification: Implementing cross-asset strategies to effectively mitigate systemic risks stemming from market volatility.
  • Global Allocation: Keeping pace with premier global assets to capture sustainable growth potential across diverse geographical regions.
  • Fluctuation Mitigation: Optimizing asset orchestration to help clients navigate economic cycles and realize long-term capital appreciation.

Through its innovative “Invesurance” framework, YF Life seamlessly integrates traditional insurance protection with institutional-grade global investment strategies, establishing a forward-looking and resilient wealth management foundation for both high-net-worth and mass-affluent clients.

Empowered by Technology: Constructing Smart Brand Assets via Advanced Technology

In terms of brand marketing and communications, YF Life has established itself as an early adopter of advanced Artificial Intelligence Generated Content (AIGC) technology within the industry. To complement the 50th-anniversary promotions, the campaign debuted two fully AI-generated brand videos that translated the abstract concepts of “Invesurance” into compelling visual narratives. By integrating high level brand storytelling with cutting-edge technology, YF Life not only optimized content production efficiency but also established a rapid iterative, intelligent brand asset, setting a new paradigm for insurance marketing.

An Omnichannel Ecosystem: Generating Scalable Strategic Resonance

The campaign deployed an integrated, omnichannel communications strategy, ensuring seamless synergy between digital touchpoints and offline engagements. Digitally, the brand executed systematic content operations across major social media platforms to drive sustained market buzz and interactive user engagement. For offline, strategic outdoor placements in prime Hong Kong and Macau commercial districts utilized a modern, high recognition visual identity to maximize brand presence and resonance.

Looking Ahead: Fueling “Envision, Invesurance” through Driven Innovation

Moving forward, YF Life will continue to deepen the operational integration and practical application of its “Invesurance” philosophy. By Leveraging its digital transformation strengths and technological ecosystem, the company is committed to tailoring client experiences and strategically positioned to capture HNW and next-generation market segments. Through scalable brand narratives and superior digital experiences, YF Life continues to translate its core brand values—”Envision, Invesurance”—into tangible customer value, steering the insurance industry toward a high-specification, intelligent future.

Hashtag: #YFLife

The issuer is solely responsible for the content of this announcement.

Holistic Way Unveils New Plant-Based Menopause Relief Supplement


SINGAPORE – Media OutReach Newswire – 6 August 2026 – JR Life Sciences Pte Ltd, the company behind Singapore’s No. 1 Health-Supplement Brand, Holistic Way, announced the launch of its newest innovation in women’s health: a plant-based Menopause Relief supplement formulated to support women through every stage of menopause. The product is officially released this month, underscoring the company’s deepening commitment to addressing the evolving health needs of women in Singapore and across the region.

As awareness around women’s health continues to grow, menopause remains a life stage that is frequently underserved by mainstream health solutions. JR Life Sciences is responding to this gap with a science-backed, plant-derived formulation that offers a natural alternative to conventional hormone-based therapies, one that is both accessible and aligned with the preferences of today’s health-conscious consumer.

Menopause Relief is a once-daily capsule containing three plant-based phytoestrogens, each selected for their clinically studied benefits in managing menopause symptoms and supporting long-term health. The formulation is free from synthetic hormones and is suitable for both vegetarian and vegan diets, making it broadly accessible across diverse consumer lifestyles.

Key active ingredients include:

  • Lifenol Hops Extract (8-PN phytoestrogen): Shown to lessen hot flushes, night sweats, sleep disturbances, restlessness and irritability while helping to maintain total-body bone-mineral density.
  • Flax Lignan (SDG phytoestrogen): Provides gentle hormonal support that helps balance oestrogen levels during the transition.
  • Soy Isoflavone (genistein and daidzein): Supports bone strength, reduces hot flashes and steadies mild mood swings.

The launch of Menopause Relief reflects a broader strategic priority for JR Life Sciences: to expand its women’s health portfolio in response to growing consumer demand for natural health solutions. In Singapore, where an ageing population is driving increased interest in preventive health and targeted supplementation, the company sees a significant opportunity to better serve women navigating the menopause transition.

Holistic Way currently distributes a comprehensive range of nutraceuticals across key health categories, including:

As JR Life Sciences prepares for 2027, its focus remains on addressing unmet market needs and evolving consumer expectations. Guided by a commitment to science-backed innovation and quality, the company continues to invest in building a future-ready product pipeline that supports long-term well-being and reinforces trust among consumers in Singapore and beyond.

Menopause Relief is now available through Holistic Way’s retail and digital channels. For more information, visit https://holisticway.com.sg/.

Hashtag: #HolisticWay

The issuer is solely responsible for the content of this announcement.

About Holistic Way

Holistic Way is a leading Singapore-based health supplement brand under JR Life Sciences, committed to supporting holistic wellbeing through science-led nutrition. The brand offers a comprehensive range of supplements formulated to support key health areas, including immunity, hormonal balance, joint health, digestive wellness, and healthy ageing. Guided by evidence-based research and stringent quality standards, Holistic Way focuses on delivering effective, reliable solutions that address both everyday wellness needs and specific life-stage concerns. Through its emphasis on scientific integrity and product excellence, Holistic Way empowers individuals to take proactive control of their health and well-being.

Mitrade Earns AI Award While Keeping Australian Traders in the Decision Seat

MELBOURNE, Australia, Aug. 6, 2026 /PRNewswire/ — CFD broker Mitrade received Global Business Magazine’s 2026 AI Broker of the Year award as the latest AI model powering MitradeGPT rolls out in selected regions, with Australia to follow. It speaks to a central AI debate: how to accelerate research without displacing trader judgement.

Young Australians are testing AI for financial research, even as regulators urge caution over its limits. ASIC’s “Moneysmart Gen Z Financial Behaviours Report 2026” found 18% of Gen Z Australians use AI for financial information, while 64% trust AI platforms for financial guidance. Against that backdrop, Mitrade’s principle is straightforward: AI should support research, not make trading decisions.

That principle shapes the latest model behind MitradeGPT, an AI research tool already on Mitrade’s platform outside the EU. The new AI model is now live in several regions Mitrade provides services for, with Australia planned for a later phase. Where available, MitradeGPT organises news research in one place: finding related coverage, sorting it into categories, grouping key developments, and extracting main viewpoints.

For traders, that means less repetitive research, less noise to sift through, and clearer market context.

“AI can process information at a remarkable speed, but it cannot replace human judgement,” said Elven Jong, CEO of Mitrade AU. “Its proper role is not to tell traders what to do, but to reduce information overload and make market context easier to understand. At Mitrade, we focus on providing clearer context and education so traders can question the information, weigh competing views and retain control over every decision.”

Mitrade also recently received Global Business Review Magazine’s Most Trusted CFD Broker – Global 2026 and World Business Stars Magazine’s Best New CFD Broker LATAM 2026 and Most Reliable Broker Global 2026.

About Mitrade  
Mitrade is an award-winning CFD trading platform founded in Melbourne, trusted by 7M+ traders worldwide. It operates under top-tier financial regulators—Australia’s ASIC (AFSL398528), Cyprus’ CySEC (CIF438/23), UAE’s CMA (License No. 20200000397), Cayman Islands’ CIMA (SIB1612446), South Africa’s FSCA (54842), and Mauritius’s FSC (GB20025791)—delivering a secure, seamless, and intuitive trading experience.  

The platform provides 1,000+ CFDs on indices, forex, commodities, ETFs, and shares. Mitrade redefines trading with millisecond execution, razor-thin spreads, robust risk management, and multi-device compatibility.  

Trading involves risks. This article is for informational purposes only and does not constitute financial advice, an offer, or a solicitation.  

Visit https://www.mitrade.com for more information.

Manulife announces $3.2 billion long-term care reinsurance transaction with Munich Re

• Company’s third LTC reinsurance transaction and first on a standalone LTC block, highlighting Manulife’s ability to transact in various structures
• Full risk transfer on the biometric risk with no asset transfer
• Upon closing, Manulife will have cumulatively reduced LTC risk by 24%

TORONTO, Aug. 6, 2026 /PRNewswire/ — Manulife Financial Corporation (“Manulife” or the “Company”) announced today that it has agreed to reinsure biometric risk1 on a block of long-term care (“LTC”) policies with $3.2 billion of reserves2 to Munich American Reassurance Company (“Munich Re Life US”), a subsidiary of Munich Re Group, highlighting the Company’s continued efforts to reduce the risk profile of its inforce portfolio. The transaction is expected to close in Q4 2026 pending regulatory approvals.

Key highlights of the transaction include:

  • Full risk transfer on biometric risk3 on $3.2 billion of LTC reserves to Munich Re Life US
  • Inclusive of our previous LTC reinsurance transactions4, upon closing Manulife will have cumulatively reduced LTC morbidity sensitivity by 24%5
  • Similar pricing to prior deals, with a modest negative 5% cede6, further validating reserves and assumptions
  • Transaction largely neutral to capital, with immaterial annual impact to both core earnings and net income attributed to shareholders of ~$30 million in the first year and reducing over time7

“Today’s announcement represents our third LTC reinsurance transaction in under three years and first on a standalone LTC block, reflecting our ability to reduce our risk profile and strengthen our business through innovative actions. Looking ahead, we continue to see meaningful opportunities to improve our long-term care portfolio through organic initiatives that will enhance risk-adjusted returns and generate significant shareholder value.”

– Phil Witherington, President & Chief Executive Officer, Manulife

Slides related to this announcement are included as part of the 2Q26 earnings presentation available here: 2Q26 results presentation 

About Manulife

Manulife Financial Corporation is a leading international financial services provider, headquartered in Toronto, Canada. Anchored in our ambition to be the number one choice for customers, we operate as Manulife across Canada and Asia, and primarily as John Hancock in the United States, providing financial advice, insurance and health solutions for individuals, groups and businesses. Through Manulife Wealth & Asset Management, we offer global investment solutions, financial advice, and retirement plan services to individuals, institutions, and retirement plan members worldwide. At the end of 2025, we had more than 37,000 employees, over 106,000 agents, and thousands of distribution partners, serving over 37 million customers with operations across 25 markets globally. We trade as ‘MFC’ on the Toronto, New York, and Philippine stock exchanges, and under ‘945’ on the Hong Kong stock exchange.

About Munich Re Life US

Munich Re Life US, a subsidiary of Munich Re Group, is a leading US reinsurer with a significant market presence and extensive technical depth in all areas of life and disability reinsurance. Beyond vast reinsurance capacity and unrivaled risk expertise, the company is recognized as an innovator in digital transformation and aims to guide carriers through the changing industry landscape with dynamic solutions insightfully designed to grow and support their business. Munich Re Life US also offers tailored financial reinsurance solutions to help life and disability insurance carriers manage organic growth and capital efficiency as well as M&A support to help achieve transaction success.

Non-GAAP and other financial measures

Manulife prepares its Consolidated Financial Statements in accordance with International Financial Reporting Standards (“IFRS”) as issued by the International Accounting Standards Board. We use a number of non-GAAP and other financial measures to evaluate overall performance and to assess each of our businesses. Core earnings is a non-GAAP financial measure. For more information on the non-GAAP financial measures and non-GAAP ratios in this document please see section E3 “Non-GAAP and other financial measures” of the 2Q26 MD&A which is incorporated by reference and available on the SEDAR+ website at www.sedarplus.com.

Caution regarding forward-looking statements

This document contains forward-looking statements within the meaning of the “safe harbour” provisions of Canadian provincial securities laws and the U.S. Private Securities Litigation Reform Act of 1995, including statements regarding the expected timing and closing of the reinsurance transaction described herein and its expected impact and future opportunities to improve our long-term care portfolio.

Although we believe that the expectations reflected in such forward-looking statements are reasonable, such statements involve risks and uncertainties, and undue reliance should not be placed on such statements. Certain material factors or assumptions are applied in making forward-looking statements, and actual results may differ materially from those expressed or implied in such statements. Important factors and assumptions that could cause actual results to differ materially from expectations include but are not limited to the receipt of required regulatory approvals, satisfaction of customary closing conditions, the accuracy of actuarial assumptions and reserve estimates, changes in economic, market or regulatory conditions, the accuracy of information received from counterparties and the ability of counterparties to meet their obligations. Additional information regarding material risk factors may be found in our most recent annual and interim reports and other filings with Canadian and U.S. securities regulators.

The forward-looking statements in this document are stated as of the date hereof and, except as required by law, we do not undertake to update any forward-looking statements.

Media Inquiries

Fiona McLean
(437) 441-7491
fiona_mclean@manulife.com

Investor Relations

Derek Theobalds
(416) 254-1774
derek_theobalds@manulife.com

_________________________________________

Note: All figures and estimates are based on June 30, 2026, position, unless otherwise noted, and are expressed in Canadian dollar, based on exchange rate of US$1:00 to C$1.41875. Foregone core earnings and net income attributed to shareholders impacts based on exchange rate of US$1:00 to C$1.38398.

1

IFRS reserve figure of C$3.2B at 80% quota share. 

2

IFRS reserve figure of C$3.2B at 80% quota share, reflecting IFRS 17 current estimate of present value of future cash flows + risk adjustment + contractual service margin.

3

IFRS reserve figure of C$3.2B at 80% quota share.

4

Refers to the $13 billion reinsurance transaction, including $6 billion of LTC, with Global Atlantic that was announced in December 2023 and closed in February 2024 and the $5.4 billion reinsurance transaction with RGA, including $2.4 billion of LTC that was announced in November 2024 and closed in January 2025.

5

Impact of a change in reserves would be reported through the contractual service margin, net income attributed to shareholders, and other comprehensive income attributed to shareholders. In reference to the cumulative reduction in LTC morbidity sensitivity across all three transactions at the time of the respective announcement. Note sensitivity for this transaction based on 2Q26. Transaction is expected to close in 4Q26 pending regulatory approvals.

6

On IFRS basis.

7

Core earnings is a non-GAAP financial measure. 

OceanaGold Reports Second Quarter 2026 Results

(All financial figures in United States dollars unless otherwise stated)

  • Produced 138,800 ounces of gold, on track to deliver on full year guidance.
  • Strong Free Cash Flow of $130 million, with cash of $655 million and no debt at quarter end.
  • Advanced growth projects and returned $78 million to shareholders via buybacks and dividends.

VANCOUVER, BC, Aug. 6, 2026 /PRNewswire/ — OceanaGold Corporation (TSX: OGC) (NYSE: OGC) (“OceanaGold” or the “Company”) reported its operational and financial results for the three and six months ended June 30, 2026. The consolidated financial statements and Management’s Discussion and Analysis (“MD&A”) are available at www.oceanagold.com.

Second Quarter Highlights

  • On track to achieve full year production, cost and capital guidance, with production expected to increase and costs to decrease in the second half of 2026.
  • Safely and responsibly produced 138,800 ounces of gold and 2,700 tonnes of copper, an increase in gold production of 7% from the prior quarter.
  • All-In Sustaining Cost (“AISC”) of $2,151 per ounce in the quarter, expected to decrease in the second half of 2026 with higher gold production and lower sustaining capital.
  • Revenue of $647 million at an average realized gold price of $4,433 per ounce, reflecting gold sales weighted towards the end of the quarter as gold production increased at Haile.
  • Net profit1 of $222 million, EPS of $0.99 and record adjusted EBITDA Margin of 61%.
  • Generated strong quarterly Operating Cash Flow of $314 million.
  • Free Cash Flowof $130 million, and $385 million year to date.
  • Cash balance increased by 6% to $655 million with no debt and revolving credit facility undrawn.
  • Returned $78 million to shareholders in the quarter, via dividends and share buybacks.
  • Completed $58 million in share buybacks during the quarter and $134 million year to date, with up to $350 million approved for 2026.
  • Listed on the New York Stock Exchange (“NYSE”) on April 7, 2026, with trading volumes increasing.
  • Reported additional high-grade drill results at Haile, highlighting the ongoing success of drilling to support resource growth and conversion, and continuing to demonstrate upside potential.
  • Development of the decline towards Wharekirauponga commenced in May 2026, progressing to plan.
  • Macraes produced its 6 millionth ounce of gold in July 2026, since beginning production in 1990.

† See “Non-IFRS Financial Information” 
1 Attributable to the shareholders of the Company.

Gerard Bond, President and CEO of OceanaGold, said “We are pleased to deliver another quarter of solid gold production, generating strong free cash flow which allows us to invest in our attractive organic growth projects, strengthen our balance sheet and still return meaningful capital to shareholders. During the quarter we commenced development of the decline towards the high-grade Wharekirauponga orebody, a significant milestone in advancing the Waihi North Project, and are progressing to plan. At Haile, we continued to progress the Palomino decline and released additional high-grade drill results that further demonstrate our ability to add value through the drill bit. With increased gold production expected in the second half of the year we remain focused on delivering on our guidance, reducing our unit costs, generating further free cash flow and continuing to create value for our shareholders.”

Results Overview

Q2 2026

Q1 2026

Q2 2025

YTD 2026

YTD 2025

Gold Produced1

  Haile

koz

59.5

41.6

47.7

101.1

99.3

  Macraes

koz

41.4

51.5

30.0

92.9

58.4

  Waihi

koz

16.5

16.6

17.3

33.1

34.1

  Didipio

koz

21.4

20.4

24.5

41.8

45.1

Total gold produced1

koz

138.8

130.1

119.5

268.9

236.9

Gold Sales

  Haile

koz

53.1

47.3

49.5

100.4

106.7

  Macraes

koz

45.9

47.9

34.8

93.8

58.5

  Waihi

koz

16.4

17.6

16.4

34.0

32.3

  Didipio

koz

20.4

22.6

20.6

43.0

38.4

Total Gold sales

koz

135.8

135.4

121.3

271.2

235.9

Average Gold Price

$/oz

4,433

4,894

3,293

4,663

3,082

Copper Produced1 – Didipio

kt

2.7

3.2

3.7

5.9

7.1

Copper Sales1 – Didipio

kt

2.6

3.3

3.0

5.9

6.2

Average Copper Price

$/lb

6.40

6.10

4.36

6.23

4.32

Silver Produced

koz

126.8

130.7

160.1

257.5

322.8

Cash Costs

  Haile

$/oz

1,442

1,779

997

1,601

846

  Macraes

$/oz

1,237

970

1,496

1,101

1,444

  Waihi

$/oz

2,262

1,556

1,670

1,896

1,559

  Didipio

$/oz

706

748

873

728

872

Consolidated Cash Costs

$/oz

1,362

1,292

1,210

1,327

1,096

AISC

  Haile

$/oz

1,953

2,637

1,890

2,275

1,708

  Macraes

$/oz

1,932

1,506

2,146

1,715

2,213

  Waihi

$/oz

2,840

2,155

2,190

2,485

2,106

  Didipio

$/oz

1,589

1,298

1,287

1,436

1,214

Consolidated AISC

$/oz

2,151

2,094

2,027

2,123

1,915

Free Cash Flow

$M

130.1

255.2

120.1

385.3

188.9

Net profit2

$M

222.2

228.4

114.1

450.6

213.8

Adjusted net profit2

$M

221.2

229.5

116.5

450.7

217.2

EBITDA

$M

399.0

416.7

217.1

815.7

409.1

Adjusted EBITDA

$M

398.0

417.8

219.5

815.8

412.5

Earnings per share – diluted2,3

$/share

$0.99

$1.01

$0.49

$1.99

$0.91

Adjusted earnings per share – diluted†2,3

$/share

$0.98

$1.01

$0.51

$2.00

$0.94

1     Production is reported on a 100% basis as all operations are controlled by OceanaGold.

2     Attributable to the shareholders of the Company.

3     Quarterly amounts do not sum to year-to-date amounts due to the weighting of the number of shares outstanding.

Outlook

The Company’s 2026 production, cost and capital Guidance is outlined in the table below and remains unchanged.

Production is expected to increase in the second half of the year, with consolidated third quarter production expected to be similar to the second quarter, and the fourth quarter being the strongest of the year.

At Haile, gold production is expected to increase in the third quarter, then again in the fourth quarter driven by higher grades mined in the Ledbetter Phase 3 open pit and the Horseshoe Underground. Macraes production is expected to be lower in the third and fourth quarters as per plan, while production at Waihi is expected to remain relatively consistent through the remainder of the year. At Didipio, production is expected to be higher in the third and fourth quarters driven by an increase in underground mining rates.

Consolidated AISCis anticipated to be near the upper end of the Company’s 2026 Guidance range, reflecting labour cost inflation, continued investment in maintenance and reliability improvements, unhedged energy costs and lower silver by-product credits. Consolidated AISCis expected to be lower in the third quarter and again in the fourth quarter, underpinned by lower sustaining capital and higher production at Haile. AISC at each of Haile, Didipio and Waihi is expected to reduce in the second half of the year. AISC at Macraes is expected to increase in the second half, with its full-year AISC expected to be within its Guidance range.

Total capital investment guidance remains unchanged, with spending on growth capital expected to increase in the second half of the year, primarily driven by the continued investment in the Waihi North and Palomino Underground Projects and waste stripping activities at Haile, while sustaining capital across the portfolio is expected to decrease in the second half of the year.

2026 Full-Year Guidance

Production & Costs1

Haile

Macraes

Waihi

Didipio

Consolidated

Gold Production

koz

235

260

135

155

60

75

85

105

520

590

Copper Production

kt

13

15

13

15

Cash Costs†,2

$/oz

970

1,070

1,275

1,375

1,600

1,800

615

715

1,050

1,200

AISC†,2

$/oz

1,500

1,700

1,950

2,150

2,100

2,300

975

1,100

1,750

1,900

† See “Non-IFRS Financial Information” 

Capital Investments1,3,4 ($M)

Haile

Macraes

Waihi

Didipio

Consolidated

Included in AISC

Sustaining capital

95

30

15

25

170

170

Pre-strip and Capitalized Mining

45

65

15

10

135

135

Growth

90

10

160

20

280

Exploration

10

10

25

10

60

15

Total Investments

240

115

215

65

645

320

1

Production is on a 100% basis as all operations are controlled by OceanaGold. Assumes a NZD to USD exchange rate of 0.58.

2

Includes by-product allocations based on a copper price of $5.85 per pound and a silver price of $95 per ounce.

3

Excludes capital leases.

4

Capital Investments Guidance range of ±5%; Consolidated includes corporate capital.

Waihi North Project

OceanaGold is permitted to develop and operate the Waihi North Project, which includes the high-grade Wharekirauponga Underground mine. Construction and underground tunnelling activity to the underground mine continues to ramp up with overall project development progressing on schedule for first ore in 2032.

Following completion of the portal, decline development commenced in May 2026 and is progressing in line with plan, nearing 200 metres to date. The next key milestone involves the addition of a second jumbo to begin the twin incline towards the Wharekirauponga orebody.

Execution of bulk earthworks accelerated at the Willows Portal site in the second quarter and earthwork activities related to drainage, dams, roads, magazine and the surface facilities area remain on track for completion by year-end. Construction of the services trench connecting the existing Waihi operations with the Willows surface facilities, providing power, water and communications infrastructure, was completed in July. Construction of the water treatment plant remains ongoing, with commissioning expected by the end of the third quarter. Early works activities on TSF 3 are expected to commence in the fourth quarter.

Dividend

OceanaGold has declared a $0.09 per share dividend payable in September 2026. Shareholders of record at the close of business in each jurisdiction on August 19, 2026 (the “Record Date”) will be entitled to receive payment of the dividend on September 18, 2026. The dividend payment applies to holders of record of the Company’s common shares traded on the TSX and the NYSE.

Declaration of Dividend

Wednesday August 5, 2026

Record Date

Wednesday August 19, 2026

Dividend Payment Date

Friday September 18, 2026

Dividends are payable in United States dollars. Shareholders in other jurisdictions can elect to participate in Computershare’s international payments service if they want to receive dividends in an alternative currency. This dividend qualifies as an ‘eligible dividend’ for Canadian income tax purposes.

Share Buyback

In the first half of 2026, the Company completed $134 million of share repurchases. In February, the Company announced approval to apply up to $350 million towards share buybacks in 2026. The Company recently renewed its Normal Course Issuer Bid for another 12 months.

Conference Call and Webcast:

Senior management will host a conference call and webcast to discuss the quarterly results on Thursday, August 6, 2026 at 10:00 am EDT (7:00 am PDT). To participate in the conference call, please use one of the following methods:

If you are unable to attend the call, a recording will be made available on the Company’s website.

About OceanaGold  

OceanaGold is a global intermediate gold and copper producer committed to safely and responsibly maximizing the generation of Free Cash Flow from our operations and delivering strong returns for our shareholders. We have a portfolio of four operating mines: the wholly-owned Haile Gold Mine in the United States of America; the wholly-owned Macraes and Waihi operations in New Zealand; and the 80%-owned Didipio Mine in the Philippines.

 

Cautionary Statement for Public Release 

This news release contains certain “forward-looking statements” and “forward-looking information” (collectively, “forward-looking statements”) within the meaning of applicable Canadian and United States securities laws which may include, but are not limited to, statements with respect to: the Company’s planned production, cost and capital Guidance for 2026; the future financial and operating performance of the Company and its mining projects and the anticipated benefits therefor; the development, expansion and operation of the Company’s mining projects; anticipated production levels and mine lives; the estimation, realization and classification of Mineral Reserves and Mineral Resources; costs of production; estimates of growth capital, sustaining capital, operating and exploration expenditures; costs and timing of the development of new deposits and mines; the availability of, and access to, labour, equipment, power, diesel, water and other inputs; the timing, cost and outcome of development, construction and expansion activities; timing for the execution of bulk earthworks, construction and commissioning of the water treatment plant and first ore at the Waihi North Project; costs and timing of future exploration and drilling programs, including the Company’s site and regional exploration programs; water management initiatives and strategies and tailings management initiatives at the Company’s operations; requirements for additional capital; the adequacy of current financial resources and cash reserves; governmental regulation of mining operations and exploration operations; the timing and receipt of required permits, certifications, approvals, consents and renewals under applicable legislation; the amount of and timing for anticipated purchases under the NCIB program; the payment of dividends in future periods; compliance with applicable environmental, social, health and safety and other regulatory requirements; geotechnical and operational conditions; social licence to operate and stakeholder relationships; competition for mineral properties; the availability and terms of financing; foreign operations and political, economic and regulatory conditions in the jurisdictions in which the Company operates; expectations regarding the impacts of the U.S.-Iran international conflict on the Company’s operations, including potential impacts to operating and capital costs; governmental regulation of mining operations and exploration operations; fluctuations in commodity prices, including gold, copper and silver, and foreign exchange rates; anticipated environmental risks; the limitations and adequacy of insurance coverage; title matters, disputes, claims and land access; changes in laws, taxation and accounting standards; and the timing and possible outcome of pending legal proceedings, regulatory matters and other disputes, including the appeal to the permit approval for the Waihi North Project. 

All statements in this news release that address events or developments that the Company expects to occur in the future are forward-looking statements. Forward-looking statements are statements that are not historical facts and are generally, although not always, identified by words such as “may”, “plans”, “expects”, “projects”, “is expected”, “scheduled”, “potential”, “estimates”, “forecasts”, “intends”, “targets”, “aims”, “anticipates” or “believes” or variations (including negative variations) of such words and phrases, or may be identified by statements to the effect that certain actions, events or results “may”, “could”, “would”, “should”, “might” or “will” be taken, occur or be achieved.

Forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Such risks include, among others: the risk of not achieving the Company’s production estimates, forecasts or Guidance; inaccuracy of Mineral Reserves, Mineral Resources and operating and capital cost estimates; the actual results of current and future production, development and/or exploration activities; possible variations of ore grade, metallurgy or recovery rates; changes in mine plans, project parameters or assumptions as plans continue to be refined; delays in, or inability to complete, development or construction or expansion activities or to re-commence or sustain operations as planned; failures or underperformance of plant, equipment, infrastructure or processes; geotechnical risks or events, including open pit wall stability, crown pillar failure, land subsidence and tailings dam failures; scarcity in and disruption of global supply chain and/or increases in prices, including as a result of international conflicts, such as the U.S.-Iran conflict; challenges associated with effective water management; environmental, health and safety and climate-related risks; risks related to community acceptance, stakeholder engagement and social licence to operate; competition for mineral properties and other growth opportunities; legal and regulatory challenges to current and future permits, certifications, approvals or licences; adverse judicial, regulatory or governmental decisions; delays in, or inability to obtain, financing or governmental approvals on acceptable terms; changes in laws, regulations, taxation regimes, regulated accounting standards or their interpretation or application; the risks associated with operating in foreign jurisdictions, including political instability, changes in policy or law, civil unrest, blockades or conflict; fluctuations in the prices of gold, copper and silver; general business, economic and market conditions (including changes in global, national or regional financial, credit, currency or securities markets); changes or developments in global, national or regional political and social conditions; fluctuations in foreign exchange rates, including the value of the U.S. dollar relative to the Canadian dollar, the New Zealand dollar or the Philippine peso; trade policies and tensions, including tariffs; inflationary pressure; labour availability, retention and turnover; accidents, labour disputes, work stoppages and other operational risks of the mining industry; limitations of insurance coverage or uninsured risks; the conclusions of economic evaluations, studies and models; information technology, artificial intelligence and cybersecurity risks; and those other factors identified and described in more detail in the section entitled “Risk Factors” contained in the Company’s most recent Annual Information Form and the Company’s other filings with Canadian securities regulators and the U.S. Securities and Exchange Commission (“SEC”), which are available under the Company’s profile on SEDAR+ at sedarplus.ca and on EDGAR at sec.gov, respectively, and on the Company’s website at oceanagold.com. The list is not exhaustive of the factors that may affect the Company’s forward-looking statements.

The Company’s forward-looking statements are based on the applicable assumptions and factors Management considers reasonable as of the date hereof, based on the information available to Management at such time. These assumptions and factors include, but are not limited to, assumptions and factors related to the Company’s ability to carry on current and future operations, including: exploration and development activities; the timing, extent, duration and economic viability of such operations; the accuracy and reliability of estimates, projections, forecasts, studies and assessments; the Company’s ability to meet or achieve Guidance, estimates, projections and forecasts; the availability and cost of inputs; the price and market for outputs, including gold, copper and silver; foreign exchange rates; taxation levels; the timely receipt of necessary permits, certifications, approvals or licences; the ability to meet current and future obligations; the ability to obtain timely financing on reasonable terms when required; the current and future social, economic and political conditions; and other assumptions and factors generally associated with the mining industry.

The Company’s forward-looking statements are based on the opinions and estimates of Management and reflect their current expectations regarding future events and operating performance and speak only as of the date hereof. The Company does not assume any obligation to update forward-looking statements if circumstances or Management’s beliefs, expectations or opinions should change other than as required by applicable laws. There can be no assurance that forward-looking statements will prove to be accurate, and actual results, performance or achievements could differ materially from those expressed in, or implied by, these forward-looking statements. Accordingly, no assurance can be given that any events anticipated by the forward-looking statements will transpire or occur, or if any of them do, what benefits or liabilities the Company will derive therefrom. For the reasons set forth above, undue reliance should not be placed on forward-looking statements.

Cautionary Statements for United States Readers

The scientific and technical disclosure in this news release was prepared in accordance with National Instrument 43-101 – Standards of Disclosure for Mineral Projects (“NI 43-101”), which differs from the scientific and technical disclosure requirements of the SEC that are applicable to domestic United States reporting companies. Any Mineral Reserves and Mineral Resources reported by the Company in accordance with NI 43-101 may not qualify as such under SEC standards, including Subpart 1300 of Regulation S-K under the United States Securities Exchange Act of 1934, as amended. As a foreign private issuer that is eligible to file reports with the SEC pursuant to the multi-jurisdictional disclosure system, the Company is not required to provide disclosure on its mineral properties under applicable SEC rules and regulations and provides disclosure under NI 43-101 and the Canadian Institute of Mining, Metallurgy and Petroleum (the “CIM”) – CIM Definition Standards on Mineral Resources and Mineral Reserves, adopted by the CIM Council, as amended.  Accordingly, Mineral Resources and Mineral Reserves information and other scientific and technical information contained or referenced in this news release may not be comparable to similar scientific and technical information disclosed by United States public companies subject to the reporting and technical disclosure requirements of the SEC. Historical results or feasibility models presented herein are not guarantees or expectations of future performance.

Qualified Persons

Mr. Greg Hollett, the Company’s Head of Mine Engineering, a qualified person as defined by NI 43-101, has reviewed and approved the disclosure of all scientific and technical information related to Haile operational matters contained in this news release.

Mr. Euan Leslie, the Company’s Group Mining Engineer, and Mr. Knowell Madambi, the Company’s Manager – Technical Services & Projects, Macraes, each of whom is a qualified person as defined by NI 43-101, have reviewed and approved the disclosure of all scientific and technical information related to Macraes operational matters contained in this news release.

Messrs. Leslie and David Townsend, the Company’s Manager – Mining (Underground), Waihi, each of whom is a qualified person as defined by NI 43-101, have reviewed and approved the disclosure of all scientific and technical information related to Waihi operational matters contained in this news release.

Mr. Phillip Jones, the Company’s Head of Underground Mining, a qualified person as defined by NI 43-101, has reviewed and approved the disclosure of all scientific and technical information related to Didipio operational matters contained in this news release.

Mr. Keenan Jennings, the Company’s Executive Vice President and Chief Exploration Officer, a qualified person as defined by NI 43-101, has approved the scientific and technical information regarding exploration matters contained in this news release.

Non-IFRS Financial Information

Adjusted Net Profit/(Loss) and Adjusted Earnings/(Loss) per share

These are used by Management to measure the underlying operating performance of the Company. Management believes these measures provide information that is useful to investors because they are important indicators of the strength of the Company’s operations and the performance of its core business. Accordingly, such measures are intended to provide additional information and should not be considered in isolation as a substitute for measures of performance prepared in accordance with IFRS. Adjusted net profit/(loss) is calculated as net profit/(loss) less the impact of non-recurring items and significant recurring non-cash items. Including impairment expenses and reversals, write-downs, foreign exchange (gains)/losses, gain on sale of assets and listing costs. Management believes that the presentation of Adjusted Net Profit/(Loss) and Adjusted Earnings/(Loss) per share is appropriate to provide additional information to investors regarding items that Management does not expect to continue at the same level in the future or that Management does not believe to be a reflection of the Company’s ongoing operating performance.

The following table provides a reconciliation of Adjusted Net Profit/(Loss) and Adjusted Earnings/(Loss) per share:

$M, except per share amounts

Q2 2026

Q1 2026

Q2 2025

YTD 2026

YTD 2025

Net profit1

222.2

228.4

114.1

450.6

213.8

Foreign exchange (gain) loss

(2.0)

0.1

2.4

(1.9)

3.2

NYSE listing costs

0.9

1.0

1.9

Write-down of assets

0.1

0.1

0.2

Adjusted net profit1

221.2

229.5

116.5

450.7

217.2

Weighted average number of common shares – fully diluted

225.1

226.6

234.8

225.9

235.4

Adjusted earnings per share

0.98

1.01

0.51

2.00

0.94

1     Attributable to the shareholders of the Company.

EBITDA, Adjusted EBITDA and Adjusted EBITDA Margin

Management believes that Adjusted EBITDA is a valuable indicator of its ability to generate liquidity by producing operating cash flows to fund working capital needs, service debt obligations and fund capital expenditures. EBITDA is defined as earnings before interest, tax, depreciation and amortization. Adjusted EBITDA is calculated as EBITDA less the impact of non-recurring items and significant recurring non-cash items. Including impairment expenses and reversals, write-downs, gains/losses on disposal of assets, listing costs, foreign exchange gains/losses and other non-recurring costs. Adjusted EBITDA Margin is calculated as Adjusted EBITDA divided by revenue.

The following table provides a reconciliation of EBITDA, Adjusted EBITDA and Adjusted EBITDA Margin

$M

Q2 2026

Q1 2026

Q2 2025

YTD 2026

YTD 2025

Net profit

228.7

235.4

117.6

464.1

218.8

Depreciation and amortization

86.7

84.0

54.9

170.7

108.6

Net interest (income) expense and finance costs

0.7

(1.0)

1.5

(0.3)

3.3

Income tax expense on earnings

82.9

98.3

43.1

181.2

78.4

EBITDA

399.0

416.7

217.1

815.7

409.1

Foreign exchange (gain) loss

(2.0)

0.1

2.4

(1.9)

3.2

NYSE listing costs

0.9

1.0

1.9

Write-down of assets

0.1

0.1

0.2

Adjusted EBITDA

398.0

417.8

219.5

815.8

412.5

Revenue

647.3

714.5

432.4

1,361.8

792.3

Adjusted EBITDA Margin

61 %

58 %

51 %

60 %

52 %

Cash Costs and AISC

Cash Costs are a common financial performance measure in the gold mining industry; however, it has no standard meaning under IFRS. Management uses this measure to monitor the performance of the Company’s mining operations and its ability to generate positive cash flows, both on an individual site basis and an overall company basis. Cash Costs include mine site operating costs plus indirect taxes and selling cost net of by-product allocations and are then divided by ounces sold. In calculating Cash Costs, the Company includes the value of cash-settled stock-based compensation in the year of vesting. Cash Costs are reduced by copper and silver by-product cost allocations that are considered incidental to the gold production process, thereby allowing Management and other stakeholders to assess the net costs of gold production. The measure is not necessarily indicative of cash flow from operations under IFRS or operating costs presented under IFRS.

Management believes that the AISC measure provides additional insight into the costs of producing gold by capturing all of the expenditures required for the discovery, development and sustaining of gold production and allows the Company to assess its ability to support capital expenditures to sustain future production from the generation of operating cash flows, both on an individual site basis and an overall company basis, while maintaining current production levels. Management believes that, in addition to conventional measures prepared in accordance with IFRS, certain investors use this information to evaluate the Company’s performance and ability to generate cash flow per ounce sold. AISC is calculated as the sum of Cash Costs, capital expenditures and exploration costs that are sustaining in nature and corporate G&A costs. AISC is divided by ounces sold to arrive at AISC per ounce.

 The following table provides a reconciliation of consolidated Cash Costs and AISC:

$M, except per oz amounts

Q2 2026

Q1 2026

Q2 2025

YTD 2026

YTD 2025

Cost of sales, excl. depreciation and amortization

215.1

226.8

181.1

441.9

324.0

Indirect taxes

7.6

9.0

5.6

16.6

10.4

Selling costs

0.5

3.7

2.6

4.2

5.4

Non-cash stock-based compensation adjustments2

7.4

(9.0)

(7.1)

(1.6)

(10.5)

By-product allocation

(45.7)

(55.6)

(35.4)

(101.3)

(70.7)

Total Cash Costs (net)

184.9

174.9

146.8

359.8

258.6

Sustaining capital and leases

51.1

40.3

34.4

91.4

61.2

Deferred stripping and capitalized mining

31.3

45.9

49.0

77.2

104.3

Corporate general & administration3

21.3

19.9

15.1

41.2

25.5

Onsite exploration and drilling

3.4

3.2

0.6

6.6

2.2

Total AISC

292.0

284.2

245.9

576.2

451.8

Gold sales (koz)

135.8

135.4

121.3

271.2

235.9

Cash Costs ($/oz)

1,362

1,292

1,210

1,327

1,096

AISC ($/oz)1

2,151

2,094

2,027

2,123

1,915

1

Excludes the Additional Government Share related to the FTAA at Didipio of $9.7 million,  $22.1 million and $31.8 million for the second quarter,  first quarter and year to date 2026, respectively, as it is considered in the nature of an income tax.

2

Other cash adjustments reflect the inclusion of cash settled stock-based compensation in AISC over the year of vesting.

3

Corporate general & administration includes cash settled stock-based compensation.

The following tables provide a reconciliation of Cash Costs and AISC for each operation:

Haile

$M, except per oz amounts

Q2 2026

Q1 2026

Q2 2025

YTD 2026

YTD 2025

Cash costs of sales1

95.1

79.8

53.9

174.9

99.5

By-product allocation

(1.7)

(1.2)

(1.9)

(2.9)

(3.8)

Inventory adjustments

(16.9)

5.4

(2.8)

(11.5)

(5.8)

Freight, treatment and refining charges

0.1

0.2

0.2

0.3

0.4

Total Cash Costs (net)

76.6

84.2

49.4

160.8

90.3

Sustaining capital and leases

26.3

18.7

16.2

45.0

26.6

Deferred stripping and capitalized mining

21.2

28.0

21.2

64.4

Onsite exploration and drilling

0.6

0.9

0.1

1.5

0.9

Total AISC

103.5

125.0

93.7

228.5

182.2

Gold sales (koz)

53.1

47.3

49.6

100.4

106.7

Cash Costs ($/oz)

1,442

1,779

997

1,601

846

AISC ($/oz)

1,953

2,637

1,890

2,275

1,708

1     Reflects the inclusion of cash settled stock-based compensation over the year of vesting.

Macraes

$M, except per oz amounts

Q2 2026

Q1 2026

Q2 2025

YTD 2026

YTD 2025

Cash costs of sales1

44.5

45.1

43.3

89.6

82.5

By-product allocation

(0.2)

(0.1)

(0.3)

(0.1)

Royalties

6.9

6.7

2.6

13.6

3.3

Inventory adjustments

5.2

(5.9)

5.9

(0.7)

(1.7)

Freight, treatment and refining charges

0.4

0.6

0.3

1.0

0.5

Total Cash Costs (net)

56.8

46.4

52.1

103.2

84.5

Sustaining capital and leases

11.5

8.6

8.4

20.1

17.8

Deferred stripping and capitalized mining

18.8

15.8

14.2

34.6

26.5

Onsite exploration and drilling

1.4

1.2

0.1

2.6

0.7

Total AISC

88.5

72.0

74.8

160.5

129.5

Gold sales (koz)

45.9

47.9

34.8

93.8

58.5

Cash Costs ($/oz)

1,237

970

1,496

1,101

1,444

AISC ($/oz)

1,932

1,506

2,146

1,715

2,213

1     Reflects the inclusion of cash settled stock-based compensation over the year of vesting.

Waihi

$M, except per oz amounts

Q2 2026

Q1 2026

Q2 2025

YTD 2026

YTD 2025

Cash costs of sales1

34.9

34.2

30.7

69.1

57.5

By-product allocation

(4.6)

(6.3)

(2.6)

(10.9)

(4.7)

Royalties

0.8

2.8

0.6

3.6

1.1

Inventory adjustments

6.0

(3.4)

(1.4)

2.6

(3.7)

Add: Freight, treatment and refining charges

0.1

0.1

0.1

Total Cash Costs (net)

37.1

27.4

27.3

64.5

50.3

Sustaining capital and leases

2.7

4.9

2.2

7.6

6.5

Deferred stripping and capitalized mining

5.7

4.7

5.7

10.4

10.4

Onsite exploration and drilling

0.9

1.1

0.5

2.0

0.7

Total AISC

46.4

38.1

35.7

84.5

67.9

Gold sales (koz)

16.4

17.6

16.3

34.0

32.3

Cash Costs ($/oz)

2,262

1,556

1,670

1,896

1,559

AISC ($/oz)

2,840

2,155

2,190

2,485

2,106

1     Reflects the inclusion of cash settled stock-based compensation over the year of vesting.

Didipio

$M, except per oz amounts

Q2 2026

Q1 2026

Q2 2025

YTD 2026

YTD 2025

Cash costs of sales1

39.4

41.1

38.3

80.5

70.4

By-product allocation

(39.2)

(48.0)

(30.9)

(87.2)

(62.1)

Royalties

2.5

3.5

2.4

6.0

4.0

Indirect taxes

7.4

8.3

5.7

15.7

10.4

Inventory adjustments

2.6

7.8

(0.7)

10.4

3.8

Freight, treatment and refining charges

1.7

4.2

3.2

5.9

7.0

Total Cash Costs (net)

14.4

16.9

18.0

31.3

33.5

Sustaining capital and leases

10.6

8.1

7.0

18.7

9.7

Deferred stripping and capitalized mining

6.8

4.2

1.1

11.0

3.0

General & administration2

0.1

0.1

0.3

0.2

0.3

Onsite exploration and drilling

0.3

0.3

Total AISC

32.2

29.3

26.4

61.5

46.5

Gold sales (koz)

20.4

22.6

20.6

43.0

38.4

Cash Costs ($/oz)

706

748

873

728

872

AISC1 ($/oz)

1,589

1,298

1,287

1,436

1,214

1

Reflects the inclusion of cash settled stock-based compensation over the year of vesting.

2

Excludes the Additional Government Share of FTAA at Didipio of $9.7 million, $22.1 million and $31.8 million for the second quarter, first quarter, and year to date 2026, respectively, as it is considered in the nature of an income tax.

Net Cash/(Debt)

Net Cash/(Debt) has been calculated as total debt plus cash and cash equivalents. Management believes this is a useful indicator to be used in conjunction with other liquidity and leverage ratios to assess the Company’s financial health.

The following table provides a reconciliation of Net Cash/(Debt):

$M

June 30, 2026

December 31, 2025

Amounts drawn under the revolving credit facility

Total debt

Cash and cash equivalents

654.8

476.5

Net Cash

654.8

476.5

Operating Cash Flow before working capital movements

Operating Cash Flow before working capital movements is calculated as the cash flows provided by operating activities adjusted for changes in working capital. The following table provides a reconciliation of Operating Cash Flow before working capital movements:

$M, except per share amounts

Q2 2026

Q1 2026

Q2 2025

YTD 2026

YTD 2025

Cash provided by operating activities

313.6

381.5

226.9

695.1

398.5

Changes in working capital

27.2

(46.9)

4.9

(19.7)

30.1

Cash flows provided by operating activities before changes in working capital

340.8

334.6

231.8

675.4

428.6

Free Cash Flow

Free Cash Flow is calculated as cash flows from operating activities, less cash flow used in investing activities. Management believes Free Cash Flow is a useful indicator of the Company’s ability to generate cash flow and operate net of all expenditures, prior to any financing cash flows. The following table provides a reconciliation of Free Cash Flow:

$M, except per share amounts

Q2 2026

Q1 2026

Q2 2025

YTD 2026

YTD 2025

Cash flows provided by Operating Activities

313.6

381.5

226.9

695.1

398.5

Cash flows used in Investing Activities

(183.5)

(126.3)

(106.8)

(309.8)

(209.6)

Free Cash Flow

130.1

255.2

120.1

385.3

188.9

For further information please contact: Investor Relations: Brian Martin, SVP, Business Development and Investor Relations, Tel: +1 604-678-4096, ir@oceanagold.com; Valerie Burns, Director, Investor Relations, Tel: +1 604-235-0742, ir@oceanagold.com; Media Relations: Louise Burgess, Vice President, Communications, Tel: +1 604-403-2019, info@oceanagold.com 

Telix to Host R&D Day in New York City on September 22, 2026

MELBOURNE, Australia and INDIANAPOLIS, Aug. 6, 2026 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today advises that it will host a Research and Development (R&D) Day on Tuesday, September 22, 2026, from 8:30 a.m. to 12:30 p.m. EDT in New York City.

Institutional investors and analysts are invited to register to attend the in-person session, which will feature a comprehensive overview of Telix’s therapeutic and precision medicine pipeline, as well as key scientific, clinical and strategic developments across the portfolio.

Members of the Telix leadership team will present at the event, including Managing Director and Group CEO, Dr. Christian Behrenbruch; Group Chief Medical Officer, Dr. David N. Cade; CEO Therapeutics, Richard Valeix; CEO Precision Medicine, Kevin Richardson and Vice President Discovery Sciences, Dr. Michael Wheatcroft. The program will also feature presentations from key opinion leaders who will provide their perspectives on the clinical and scientific opportunities.

Advance registration is required for in-person attendance. Additional event details, including the venue, agenda and presentation materials, will be provided to registered attendees.

To RSVP or inquire about the R&D Day, please contact annie.kasparian@telixpharma.com or charlene.jaw@telixpharma.com.

Capital Markets Day to be hosted in Melbourne on November 4, 2026 – Save the Date

Telix will also host a Capital Markets Day in Melbourne on Wednesday, November 4, 2026. Telix management will provide updates on the Company’s strategy, growth outlook, financial targets and key business priorities. Further details will be provided in a separate announcement.

Note: These events are for qualified institutional investors and analysts.

About Telix Pharmaceuticals Limited

Telix Pharmaceuticals (ASX: TLX, NASDAQ: TLX) is a commercial-stage global radiopharmaceutical company, advancing targeted theranostics to improve outcomes for people with cancer across the patient journey. Theranostics pairs a precision diagnostic with a targeted therapy to both diagnose and treat disease. 

Telix’s commercial franchise is anchored by its prostate cancer imaging portfolio: Illuccix® (kit for the preparation of gallium-68 gozetotide injection), commercially available in 22 countries including the U.S. and Gozellix® (kit for the preparation of gallium-68 gozetotide injection), approved by the U.S. Food and Drug Administration (FDA). The Company’s late-stage therapeutic pipeline includes three investigational assets in pivotal-stage trials: TLX591-Tx (lutetium-177 (177Lu) rosopatamab tetraxetan) in prostate cancer, TLX101-Tx (131I-iodofalan) in recurrent glioblastoma, and TLX250-Tx (lutetium (177Lu) girentuximab tetraxetan) in kidney cancer, additionally complemented by a deep pipeline of next generation candidates. 

Telix is headquartered in Melbourne, Australia, with operations across North America, Europe, Latin America and Asia-Pacific. For more information, visit www.telixpharma.com or follow Telix on LinkedIn, X and Facebook.

Investor Relations

Annie Kasparian

Annie.kasparian@telixpharma.com

 

Charlene Jaw

Charlene.jaw@telixpharma.com

Legal Notices

Cautionary Statement Regarding Forward-Looking Statements. 

You should read this announcement together with our risk factors, as disclosed in our most recently filed reports with the Australian Securities Exchange (ASX), U.S. Securities and Exchange Commission (SEC), including our Annual Report on Form 20-F filed with the SEC, or on our website.

The information contained in this announcement is not intended to be an offer for subscription, invitation or recommendation with respect to securities of Telix Pharmaceuticals Limited (Telix) in any jurisdiction, including the United States. The information and opinions contained in this announcement are subject to change without notification.  To the maximum extent permitted by law, Telix disclaims any obligation or undertaking to update or revise any information or opinions contained in this announcement, including any forward-looking statements (as referred to below), whether as a result of new information, future developments, a change in expectations or assumptions, or otherwise. No representation or warranty, express or implied, is made in relation to the accuracy or completeness of the information contained or opinions expressed in the course of this announcement.

This announcement may contain forward-looking statements, including within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, that relate to anticipated future events, financial performance, plans, strategies or business developments. Forward-looking statements can generally be identified by the use of words such as “may”, “expect”, “intend”, “plan”, “estimate”, “anticipate”, “believe”, “outlook”, “forecast” and “guidance”, or the negative of these words or other similar terms or expressions. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to differ materially from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Forward-looking statements are based on Telix’s good-faith assumptions as to the financial, market, regulatory and other risks and considerations that exist and affect Telix’s business and operations in the future and there can be no assurance that any of the assumptions will prove to be correct. In the context of Telix’s business, forward-looking statements may include, but are not limited to, statements about: the initiation, timing, progress, completion and results of Telix’s preclinical and clinical trials, and Telix’s research and development programs; Telix’s ability to advance product candidates into, enroll and successfully complete, clinical studies, including multi-national clinical trials; the timing or likelihood of regulatory filings and approvals for Telix’s product candidates, manufacturing activities and product marketing activities; Telix’s sales, marketing and distribution and manufacturing capabilities and strategies; the commercialization of Telix’s product candidates, if or when they have been approved; Telix’s ability to obtain an adequate supply of raw materials at reasonable costs for its products and product candidates; estimates of Telix’s expenses, future revenues and capital requirements; Telix’s financial performance; developments relating to Telix’s competitors and industry; the anticipated impact of U.S. and foreign tariffs and other macroeconomic conditions on Telix’s business, including as a result of war or other geopolitical conflicts; and the pricing and reimbursement of Telix’s product candidates, if and after they have been approved. Telix’s actual results, performance or achievements may be materially different from those which may be expressed or implied by such statements, and the differences may be adverse. Accordingly, you should not place undue reliance on these forward-looking statements.

Trademarks and Trade Names. All trademarks and trade names referenced in this press release are the property of Telix Pharmaceuticals Limited (Telix) or, where applicable, the property of their respective owners. For convenience, trademarks and trade names may appear without the ® or ™ symbols. Such omissions are not intended to indicate any waiver of rights by Telix or the respective owners. Trademark registration status may vary from country to country. Telix does not intend the use or display of any third-party trademarks or trade names to imply any affiliation with, endorsement by, or sponsorship from those third parties.

©2026 Telix Pharmaceuticals Limited. All rights reserved.

LingEQ Study Finds: The Most Cognitively Dense Paper in 90 Years of AI History Was Not Written About AI

 New cognitive linguistic entropy measurement finds Claude Shannon’s communications paper surpasses both the Turing Machine (1936) and the Turing Test (1950) — LingEQ Engine launched globally August 1

SILICON VALLEY, Calif., Aug. 6, 2026 /PRNewswire/ — A study applying linguistic entropy measurement to 50 landmark AI papers — spanning 1936 to 2025 — has produced a counterintuitive result: the text with the highest measured cognitive density was not written about AI. Claude Shannon’s 1948 A Mathematical Theory of Communication registers the highest LEQ (194, Linguistic Entropy Quotient) value in the entire corpus — surpassing Turing’s 1936 On Computable Numbers (LEQ 193) and Turing’s 1950 Turing Test paper (LEQ 189). GPT-3, AlphaFold, and DeepSeek-R1 cluster between 168 and 170. The 1955 Dartmouth Proposal, which named the field of artificial intelligence, registers the lowest early-period value at 150. Early AI texts created new conceptual objects and theoretical boundaries; recent landmark work, however transformative, builds within established frameworks.

90 Years Engraved by Entropy: LEQ Analysis of 50 Landmark AI Papers
90 Years Engraved by Entropy: LEQ Analysis of 50 Landmark AI Papers

The study, 90 Years Engraved by Entropy: LEQ Analysis of 50 Landmark AI Papers, is the inaugural release of the LingEQ Curation Series. Conducted using the LingEQ Engine, the study uses multiple language models as analytical instruments, calibrated against an anchor corpus to produce reproducible linguistic entropy values. Its measurements are derived entirely from the text itself, independent of authorship, publication venue, or citation history. The theoretical framework is presented in The Scale of Language, forthcoming from Springer Nature.

The research addresses a structural gap in scientific publishing. arXiv now receives over 20,000 preprints each month, while papers can spend one to two years in peer review. AI can generate increasingly polished texts, making originality and reliability harder to assess. Each submission is evaluated by two or three reviewers, introducing sampling bias and the limits of individual expertise. Foundational work may disappear into an unread database, while papers aligned with current trends can accumulate citations despite limited lasting value. Peer review measures consensus, citation counts measure influence – neither measures what a text actually contains.

LingEQ Engine opened for global public beta on August 1, 2026.

About LingEQ Technologies:

LingEQ Technologies (LingEQ.com) is an independent language measurement platform quantifying the cognitive depth of written text in the age of AI, operating across Silicon Valley, Brisbane, Hong Kong, and Shenzhen.

Media contact:
lingeqcs@lingeq.com

LingEQ
LingEQ

Diego Mesa Puyo selected as next GEF CEO and Chairperson

WASHINGTON, Aug. 6, 2026 /PRNewswire/ — The Global Environment Facility (GEF) Council today announced the selection of Diego Mesa Puyo as the family of funds’ next CEO and Chairperson. Mesa Puyo, an international leader in energy policy, economic development, and sustainability, and former Minister of Energy and Mines from Colombia, will serve an initial term of four years, aligned with the GEF-9 funding period and the last sprint towards critical 2030 environmental goals.

Diego Mesa Puyo
Diego Mesa Puyo

Before his selection as the GEF’s next CEO and Chairperson, Mesa Puyo served as Deputy Chief of the Climate Policy Division of the International Monetary Fund. As Colombia’s Minister of Energy and Mines in the 2018-2022 administration, he led one of Latin America’s most ambitious energy transition agendas, launching market reforms that mobilized more than $3 billion in private investment and accelerated the deployment of variable renewable energy from near-zero levels to one of the fastest-growing clean energy markets in the region. He also played a central role in advancing energy transition and climate action legislation, embedding sustainability objectives in economic and development policy.

“I am deeply honored to serve as the next CEO and Chairperson of the Global Environment Facility at this pivotal moment for the international community,” Mesa Puyo said. “Countries need trusted partners that can help turn ambition into action. Building on the GEF’s remarkable legacy, I look forward to working with the Secretariat, member countries, and partners around the world to achieve environmental and development goals together by integrating solutions, catalyzing investment, and delivering measurable results for people and planet.”

The GEF is the world’s largest public funder for the environment and serves international conventions on biodiversity, climate change, and pollution. Donor countries have pledged an initial $3.9 billion for an ambitious ninth replenishment of the GEF Trust Fund, reflecting a strong commitment to protect and restore nature through multilateral cooperation.

The Global Environment Facility is the world’s family of funds for the environment. As the financial mechanism for six multilateral conventions, it supports countries’ efforts to tackle the root causes of environmental degradation — advancing global goals for nature, climate, and pollution. Over the past three decades, the GEF has been the largest public funder for the environment and provided more than $27 billion in financing, primarily as grants, and mobilized another $155 billion for country-driven priority projects.

Read the full press release here in English, Spanish, and French.